TAK1 inhibitor NG25

Also Known As:

N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methyl-3-(1H-pyrrolo(2,3-b)pyridin-4-yloxy)benzamide; TAK1 inhibitor NG-25; transforming growth factor (TGF)-beta-activated kinase 1 (TAK1) inhibitor NG25

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Cao, Wen-Ming: 1 article (01/2016)
2.	Shi, Minghao: 1 article (01/2016)
3.	Wang, Hao: 1 article (01/2016)
4.	Wang, Zhenyu: 1 article (01/2016)
5.	Yu, Yang: 1 article (01/2016)
6.	Zhang, Hong: 1 article (01/2016)
7.	Zhang, Huiyuan: 1 article (01/2016)
8.	Zhao, Yanling: 1 article (01/2016)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 01/01/2016 - "TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells."

Related Drugs and Biologics

1.	Doxorubicin (Adriamycin)